REGISTERED
on 09 Jul 2019
Last Applicant/ Owned by
PO BOX 49314
Vancover
CA
V7x1L3
Serial Number
86515140 filed on 27th Jan 2015
Registration Number
5796674 registered on 09th Jul 2019
Correspondent Address
Megan K. Bowen
Filing Basis
1. intent to use
Disclaimer
NO DATA
HLS THERAPEUTICS
Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug formulation development; clinical evaluation and testing in the nature of conducting clinical trials relating to pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes, cardiovascular disorders, central nervous system (CNS) disorders, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy, neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, dermatological disorders, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases, respiratory, gastrointestinal and other metabolic disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia nervosa, anorexia, obesity and hypothyroidism, osteoporosis and other bone disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries, immunomodulatory diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and antidepressants, antivirals, antibacterial pharmaceuticals, antifungal preparations, anti-inflammatories, analgesics and other pain therapeutics, namely, pain relief medications in the nature of muscle relaxants, anti-anxiety and anti-convulsion medications and acetaminophen, pharmaceutical preparations to treat diseases of the genitourinary system in women, hormones, namely, progesterone, progestins, and estrogens, hormone receptor modulators, and osteoporosis medicines
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 86515140
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
Yes
44D Current
No
44E filed
No
44E Current
Yes
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 09th Jul 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 09th Jul 2019 | REGISTERED-PRINCIPAL REGISTER |
| 04th Jun 2019 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |
| 04th Jun 2019 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 20th May 2019 | NOTICE OF ALLOWANCE CANCELLED |
| 20th May 2019 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| 13th Apr 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 11th Apr 2019 | SOU EXTENSION 1 GRANTED |
| 11th Apr 2019 | SOU EXTENSION 1 FILED |
| 11th Apr 2019 | SOU TEAS EXTENSION RECEIVED |